PATENT CLAIM ANALYSIS

Application Number: 15935070
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "085200"]

Abstract:
A method for treating cancer and/or preventing or reducing metastasis or treating angiogenesis related disorders comprising the step of administering IL-31 or peptide which is at least about 70%, homologous to the IL-31 sequence as set forth in SEQ ID No. 1.

Claim (Index 1):
A method for treating cancer and/or preventing or reducing metastasis comprising the step of administering IL-31 or peptide which is at least about 70% homologous to the IL-31 sequence as set forth in SEQ ID No. 1, a fused protein comprising IL-31 or peptide which is at least about 70% homologous to the IL-31 sequence as set forth in SEQ ID No. 1, an agent which up-regulates IL-31, an IL-31 receptor agonist or a complex comprising either IL-31 or peptide which is at least about 70% homologous to the IL-31 sequence as set forth in SEQ ID No. 1 or a fused protein that comprises IL-31 or peptide which is at least about 70% homologous to the IL-31 sequence as set forth in SEQ ID No. 1, to a subject in need, thereby treating cancer and/or reducing or preventing metastasis.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 90.0
- Lexical Diversity: 1.15
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15608715', '15501028', '15867655', '14502757', '12186208']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7254290162743786
- 35 USC 102 Novelty (BERT): 0.5165694237542231
- Combined Prediction Score: 0.7045430570223631
- Mean Citation Score: 287.16266400000006
- Max Citation Score: 300.26953
- Similarity Product: 193.7919285551345

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test